Conversely, in individuals with overweight or obesity, HIIE protocols appear to produce similar responses in suppressing AG and subjective appetite perceptions whilst elevating GLP-1 and PYY compared to CME [23–25]. The gene discussed is PYY; the disease is obesity due to melanocortin 4 receptor deficiency.